Search clinical trials for: perennial allergic rhinitis

Total 4408 results

Pongsakorn Tantilipikorn
National Research Council of Thailand

Completed

Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais

Rhinitis, Allergic, Perennial

Thailand
Istituto per la Ricerca e l'Innovazione Biomedica

Completed

Short and Mid-term Repeatability of Active Anterior Rhinomanometry (AAR) Measurements in Paediatric Age (Rhino-Rep)

Rhinitis | Rhinitis, Allergic | Rhinitis, Allergic, Perennial | Rhinitis, Allergic, Seasonal

Italy
Hanlim Pharm. Co., Ltd.

Completed

To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients

Perennial Allergic Rhinitis

Korea, Republic of
GlaxoSmithKline

Completed

Study Of Perennial Allergic Rhinitis

Rhinitis, Allergic, Seasonal
Hanlim Pharm. Co., Ltd.

Completed

Single Dosing Clinical Trial of HL151

Rhinitis, Allergic, Perennial

Korea, Republic of
Hanlim Pharm. Co., Ltd.

Completed

Repeated Dosing Clinical Trial of HL151

Rhinitis, Allergic, Perennial

Korea, Republic of
Zhao Hong
Beijing Municipal Science & Technology Commission; China Academy of Chinese...

Completed

Effectivness and Safety of Acupuncture Combined With Moxibustion for Allergic Rhinitis

Rhinitis, Allergic, Perennial

China
GlaxoSmithKline

Completed

A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis

Rhinitis, Allergic, Perennial and Seasonal

United States
GlaxoSmithKline

Completed

Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)

Rhinitis, Allergic, Perennial

Australia, Estonia, United States, Germany, Canada, New Zealand, Russian Federation, Lithuania, Latvia
Mateon Therapeutics

Terminated

FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer

Platinum Resistant Ovarian Cancer

United States, Belgium, Germany
Ahn-Gook Pharmaceuticals Co.,Ltd
Samsung Medical Center; Seoul St. Mary's Hospital; Seoul National University... and other collaborators

Completed

Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean

Allergic Rhinitis | Perennial Allergic Rhinitis | Non-seasonal Allergic Rhinitis

Korea, Republic of
National Institute of Allergy and Infectious Diseases...
Inner-City Asthma Consortium

Completed

Subcutaneous Immunotherapy for Mouse in Adults (SCITMO)

Asthma | Perennial Allergic Rhinitis

United States
GlaxoSmithKline

Completed

Fluticasone Nasal Spray Patient Preference Study

Rhinitis, Allergic, Perennial

United States
Alcon Research

Completed

Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis

Perennial Allergic Rhinitis

United States
GlaxoSmithKline

Completed

Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q)

Rhinitis, Allergic, Perennial

United States
GlaxoSmithKline

Completed

Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal Sprays

Rhinitis, Allergic, Perennial and Seasonal

Argentina, Russian Federation, Korea, Republic of, Australia
Johann Wolfgang Goethe University Hospital

Completed

Local IgE in Subjects With Allergic or Non-allergic Rhinitis (LISA)

Perennial Rhinitis

Germany
Eun Jung Kim
DongGuk University

Unknown

The Efficacy and Safety of Cettum for Perennial Allergic Rhinitis

Rhinitis, Allergic
Alcon Research

Completed

Safety Study of Olopatadine Nasal Spray

Perennial Allergic Rhinitis

United States
ALK-Abelló A/S
Merck Sharp & Dohme LLC

Completed

A Dose-Ranging Study of the Safety and Effectiveness of MK-8237 in the Treatment of House Dust Mite (HDM) Induced Allergic Rhinitis/Rhinoconjunctivitis in Adults (MK-8237-003/P07627)

Rhinitis, Allergic, Perennial | Rhinitis, Allergic, Nonseasonal
ALK-Abelló A/S
Merck Sharp & Dohme LLC

Completed

Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)

Rhinitis, Allergic, Perennial | Rhinitis, Allergic, Nonseasonal
GlaxoSmithKline

Completed

Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study.

Rhinitis, Allergic, Perennial

United States, Argentina, Canada, France, Peru, Italy, Chile
ALK-Abelló A/S
Merck Sharp & Dohme LLC

Completed

Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)

Rhinitis, Allergic, Perennial | Rhinitis, Allergic, Nonseasonal
GlaxoSmithKline

Completed

Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental Chamber

Rhinitis, Allergic, Perennial

Germany
GlaxoSmithKline

Completed

Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis

Rhinitis, Allergic, Perennial

Japan
GlaxoSmithKline
Adelphi Real World

Completed

A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures

Rhinitis, Allergic, Perennial
GlaxoSmithKline

Completed

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis

Allergic Rhinitis | Rhinitis, Allergic, Perennial

China
GlaxoSmithKline

Completed

Pharmacokinetic Study of Levocetirizine Oral Solution

Rhinitis, Allergic, Perennial and Seasonal

Japan
GlaxoSmithKline

Completed

A Study to Assess Intranasal Repeat Dose Effect of Levocabastine in the Subjects With Allergic Rhinitis

Rhinitis, Allergic, Perennial and Seasonal

Canada
GlaxoSmithKline

Completed

A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine

Rhinitis, Allergic, Perennial and Seasonal

Australia
Merck Sharp & Dohme LLC

Completed

Post Approval Pharmacokinetic Study of Loratadine in Japanese Pediatric and Adult Patients (Study P05539)

Perennial Allergic Rhinitis
GlaxoSmithKline

Completed

A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis

Rhinitis, Allergic, Perennial

Thailand
National Institute of Allergy and Infectious Diseases...
Inner-City Asthma Consortium

Completed

Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI)

Asthma | Rhinitis, Allergic, Perennial

United States
Kyung Hee University Hospital at Gangdong
Pusan National University Hospital; DongGuk University; Kyung Hee University... and other collaborators

Unknown

Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis

Perennial Allergic Rhinitis

Korea, Republic of
ALK-Abelló A/S

Completed

Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022)

Perennial Allergic Rhinitis | Seasonal Allergic Rhinitis
GlaxoSmithKline

Completed

Perennial Allergic Rhinitis Study In Pediatric Subjects

Rhinitis, Allergic, Perennial

United States, Argentina, Slovakia, Finland, Chile, Mexico, Italy
GlaxoSmithKline

Completed

A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis

Rhinitis, Allergic, Perennial

United States
GlaxoSmithKline

Completed

Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis

Rhinitis, Allergic, Perennial

Japan
GlaxoSmithKline

Completed

Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis

Rhinitis

Japan
GlaxoSmithKline

Completed

A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR)

Rhinitis, Allergic, Perennial and Seasonal

Austria
Chong Kun Dang Pharmaceutical

Completed

Clinical Trial to Evaluate the Efficacy and Safety of CKD-342

Rhinitis, Allergic, Perennial

Korea, Republic of
GlaxoSmithKline

Completed

A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis

Rhinitis, Allergic, Perennial

Estonia, United States, Canada, Germany, Slovakia, Russian Federation, Hungary
GlaxoSmithKline

Completed

Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS

Rhinitis, Allergic, Perennial

United States
GlaxoSmithKline

Completed

Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS

Rhinitis, Allergic, Perennial

United States
AstraZeneca

Completed

Efficacy, Safety & Tolerability of Ciclesonide 200mcg Spray 4 Weeks Treatment for Intermittent & Persistent Rhinitis (SISRIP)

Seasonal Rhinitis | Perennial Rhinitis

Mexico
AstraZeneca

Completed

Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409)

Allergic Rhinitis | Perennial Allergic Rhinitis | Hay Fever

United States
AstraZeneca

Completed

To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405)

Rhinitis, Allergic, Perennial | Hay Fever

United States
AstraZeneca

Completed

Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)

Allergic Rhinitis | Perennial Allergic Rhinitis | Hay Fever

United States, Canada
AstraZeneca

Completed

To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402)

Rhinitis, Allergic, Perennial

United States
AstraZeneca

Completed

Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)

Rhinitis, Allergic, Perennial

United States

3

Subscribe